AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Jun 16, 2022
35599_dirs_2022-06-16_f0956ff9-13c8-4257-85c1-fa1ef2723b74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-06-14
Reporting Person: Brughera Marco Maria (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-14 | Stock Option (right to buy) | $5.59 | A | 20000 | Acquired | 2032-06-14 | Common Shares (20000) | Direct |
Footnotes
F1: On June 14, 2022, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.
F2: The option is 100% vested on the date of grant.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20